These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16378072)

  • 1. Combined use of the JAK3 inhibitor CP-690,550 with mycophenolate mofetil to prevent kidney allograft rejection in nonhuman primates.
    Borie DC; Larson MJ; Flores MG; Campbell A; Rousvoal G; Zhang S; Higgins JP; Ball DJ; Kudlacz EM; Brissette WH; Elliott EA; Reitz BA; Changelian PS
    Transplantation; 2005 Dec; 80(12):1756-64. PubMed ID: 16378072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates.
    Borie DC; Changelian PS; Larson MJ; Si MS; Paniagua R; Higgins JP; Holm B; Campbell A; Lau M; Zhang S; Flores MG; Rousvoal G; Hawkins J; Ball DA; Kudlacz EM; Brissette WH; Elliott EA; Reitz BA; Morris RE
    Transplantation; 2005 Apr; 79(7):791-801. PubMed ID: 15818321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement of mycophenolate mofetil with a JAK inhibitor, AS2553627, in combination with low-dose tacrolimus, for renal allograft rejection in non-human primates.
    Nakamura K; Oshima S; Maeda M; Morio H; Fukahori H; Nakanishi T; Tsujimoto S; Hirose J; Noto T; Hamakawa N; Inami M; Morokata T
    Int Immunopharmacol; 2018 Nov; 64():201-207. PubMed ID: 30195818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients.
    Busque S; Leventhal J; Brennan DC; Steinberg S; Klintmalm G; Shah T; Mulgaonkar S; Bromberg JS; Vincenti F; Hariharan S; Slakey D; Peddi VR; Fisher RA; Lawendy N; Wang C; Chan G
    Am J Transplant; 2009 Aug; 9(8):1936-45. PubMed ID: 19660021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: three-year follow-up. The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Mycophenolate Mofetil Acute Renal Rejection Study Group
    Transplantation; 2001 Apr; 71(8):1091-7. PubMed ID: 11374408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
    Changelian PS; Flanagan ME; Ball DJ; Kent CR; Magnuson KS; Martin WH; Rizzuti BJ; Sawyer PS; Perry BD; Brissette WH; McCurdy SP; Kudlacz EM; Conklyn MJ; Elliott EA; Koslov ER; Fisher MB; Strelevitz TJ; Yoon K; Whipple DA; Sun J; Munchhof MJ; Doty JL; Casavant JM; Blumenkopf TA; Hines M; Brown MF; Lillie BM; Subramanyam C; Shang-Poa C; Milici AJ; Beckius GE; Moyer JD; Su C; Woodworth TG; Gaweco AS; Beals CR; Littman BH; Fisher DA; Smith JF; Zagouras P; Magna HA; Saltarelli MJ; Johnson KS; Nelms LF; Des Etages SG; Hayes LS; Kawabata TT; Finco-Kent D; Baker DL; Larson M; Si MS; Paniagua R; Higgins J; Holm B; Reitz B; Zhou YJ; Morris RE; O'Shea JJ; Borie DC
    Science; 2003 Oct; 302(5646):875-8. PubMed ID: 14593182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of JAK3 inhibition with CP-690,550 on immune cell populations and their functions in nonhuman primate recipients of kidney allografts.
    Paniagua R; Si MS; Flores MG; Rousvoal G; Zhang S; Aalami O; Campbell A; Changelian PS; Reitz BA; Borie DC
    Transplantation; 2005 Nov; 80(9):1283-92. PubMed ID: 16314797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
    Transplantation; 1999 Aug; 68(3):391-6. PubMed ID: 10459543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring of the immunomodulatory effect of CP-690,550 by analysis of the JAK/STAT pathway in kidney transplant patients.
    Quaedackers ME; Mol W; Korevaar SS; van Gurp EA; van Ijcken WF; Chan G; Weimar W; Baan CC
    Transplantation; 2009 Oct; 88(8):1002-9. PubMed ID: 19855246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
    Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
    Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting JAK3 in kidney transplantation: current status and future options.
    Wojciechowski D; Vincenti F
    Curr Opin Organ Transplant; 2011 Dec; 16(6):614-9. PubMed ID: 21971513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
    Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
    Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of novel PKCθ selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation.
    Fukahori H; Chida N; Maeda M; Tasaki M; Kawashima T; Noto T; Tsujimoto S; Nakamura K; Oshima S; Hirose J; Higashi Y; Morokata T
    Int Immunopharmacol; 2015 Aug; 27(2):232-7. PubMed ID: 26122135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
    Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
    Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
    Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
    Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcineurin-inhibitor-sparing immunosuppressive protocols.
    Bestard O; Cruzado JM; Grinyó JM
    Transplant Proc; 2005 Nov; 37(9):3729-32. PubMed ID: 16386520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.
    Zhu B; Liu Z; Wu C; Wang P; Wang X; Xu H
    Transplant Proc; 2008 Sep; 40(7):2258-61. PubMed ID: 18790207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tofacitinib in kidney transplantation.
    Wojciechowski D; Vincenti F
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1193-9. PubMed ID: 23841583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.